Intervention not reported
Death from any cause [ · participants with type 2 diabetes mellitus Interventions
1 finding from 1 review
Death from any cause · AKI patients receiving CKRT
It is very uncertain whether CVVHD changes death from any cause compared with CVVH or CVVHDF (very low certainty).
1 finding from 1 review
Death from any cause · patients with hypertension
Enalapril plus folic acid showed no clear difference in death from any cause compared with enalapril (high certainty).
1 finding from 1 review
Intervention not reported
Death from any cause · adults with diabetes mellitus and depression
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Death from any cause · adults with diabetes mellitus and depression
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Death from any cause · patients with LADA
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Death from any cause at day 28 of · AKI patients receiving CKRT
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Death from any cause at day 28 of · AKI patients receiving CKRT
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Death from any cause at day 28 of · AKI patients receiving CKRT
It is very uncertain whether long (> 20 cm) changes death from any cause at day 28 of compared with short (≤ 20 cm) catheter (very low certainty).
1 finding from 1 review
Death from any cause at day 28 of · AKI patients receiving CKRT
It is very uncertain whether surface‐modified changes death from any cause at day 28 of compared with standard double‐lumen catheter with identical geometry and flow design (very low certainty).
1 finding from 1 review
Death from any cause at day 28 of · AKI patients receiving CKRT
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Death from any cause at day 28 of · AKI patients receiving CKRT
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Death from any cause at day 28 of · AKI patients receiving CKRT
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Death from any cause at day 28 of · AKI patients receiving CKRT
It is very uncertain whether CVVHDF changes death from any cause at day 28 of compared with CVVH (very low certainty).
1 finding from 1 review
Overall survival (time interval between enrolment in the study and death of the person from any cause) · adults with non‐advanced colorectal cancer treated surgically or with neoadjuvant or adjuvant therapy, or both
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found